{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:15:50Z","timestamp":1755598550373},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>An estimate of fetal fraction (FF) is needed for DNA-based screening for trisomy 21 and other aneuploidies, but there is no gold standard to validate FF measurement methods. We specify a gold standard and use it to validate a method of measuring FF (SeqFF) in singleton pregnancies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>The gold standard was a formula derived from 2 elements: (a) an estimate of the percentage of DNA fragments in maternal plasma from chromosome 21 (%Ch21) in pregnancies without trisomy 21, 18, or 13 (PU) and (b) calculation of %Ch21 with increasing FF in trisomy 21 pregnancies (P21). The SeqFF method was evaluated by plotting regression lines of %Ch21 and SeqFF estimates of FF in 31 singleton male and 31 female trisomy 21 pregnancies and comparing the regressions with the reference line derived from the gold standard formula.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The gold standard formula was P21 = (1\/2)PUFF + PU, with FF expressed as a proportion, or converting %Ch21 to multiples of the median (MoM), P21(MoM) = (1\/2)FF + 1. Based on 3865 pregnancies, the PU was 1.2935%. The regression lines for trisomy 21 pregnancies with male and female fetuses were almost identical to the gold standard reference line (regression slopes in MoMs 0.52 and 0.50, respectively, compared with 0.50 for the gold standard reference line).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The proposed gold standard can be used to validate different methods of estimating FF in singleton pregnancies. SeqFF is an accurate method of estimating FF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1373\/clinchem.2018.288670","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T12:14:50Z","timestamp":1530015290000},"page":"1394-1399","source":"Crossref","is-referenced-by-count":9,"title":["Specifying a Gold Standard for the Validation of Fetal Fraction Estimation in Prenatal Screening"],"prefix":"10.1093","volume":"64","author":[{"given":"Nicholas J","family":"Wald","sequence":"first","affiliation":[{"name":"Wolfson Institute of Preventive Medicine, Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"King Wai","family":"Lau","sequence":"first","affiliation":[{"name":"Wolfson Institute of Preventive Medicine, Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P","family":"Bestwick","sequence":"first","affiliation":[{"name":"Wolfson Institute of Preventive Medicine, Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W","family":"Old","sequence":"first","affiliation":[{"name":"Wolfson Institute of Preventive Medicine, Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne J","family":"Huttly","sequence":"first","affiliation":[{"name":"Wolfson Institute of Preventive Medicine, Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Cheng","sequence":"first","affiliation":[{"name":"Wolfson Institute of Preventive Medicine, Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"key":"2020022606050310200_B1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/gim.2011.73","article-title":"DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study","volume":"14","author":"Palomaki","year":"2012","journal-title":"Genet Med"},{"key":"2020022606050310200_B2","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","article-title":"Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022606050310200_B3","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood","volume":"105","author":"Fan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022606050310200_B4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pd.4126","article-title":"The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies","volume":"33","author":"Canick","year":"2013","journal-title":"Prenat Diagn"},{"key":"2020022606050310200_B5","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1373\/clinchem.2006.074997","article-title":"Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis","volume":"52","author":"Chan","year":"2006","journal-title":"Clin Chem"},{"key":"2020022606050310200_B6","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1093\/bioinformatics\/bts549","article-title":"FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma","volume":"28","author":"Jiang","year":"2012","journal-title":"Bioinformatics"},{"key":"2020022606050310200_B7","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1073\/pnas.1406103111","article-title":"Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing","volume":"111","author":"Yu","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022606050310200_B8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/pd.5079","article-title":"Comparing methods for fetal fraction determination and quality control of NIPT samples","volume":"37","author":"Van Beek","year":"2017","journal-title":"Prenat Diagn"},{"key":"2020022606050310200_B9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/pd.4615","article-title":"Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts","volume":"35","author":"Kim","year":"2015","journal-title":"Prenat Diagn"},{"key":"2020022606050310200_B10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000455025","article-title":"The IONA test: development of an automated cell-free DNA-based screening test for fetal trisomies 13, 18 and 21 that employs the Ion Proton semiconductor sequencing platform","volume":"42","author":"Crea","year":"2017","journal-title":"Fetal Diagn Ther"},{"key":"2020022606050310200_B11","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.188","article-title":"Prenatal reflex DNA screening for trisomies 21, 18 and 13","author":"Wald","year":"2017","journal-title":"Genet Med"},{"key":"2020022606050310200_B12","unstructured":"Ensembl release 91, December 2017. http:\/\/Dec2017.archive.ensembl.org\/Homo_sapiens\/Location\/Genome?r=Y:1-1000 (Accessed January 2018)."}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/9\/1394\/32643089\/clinchem1394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/64\/9\/1394\/32643089\/clinchem1394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T06:13:21Z","timestamp":1582697601000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/64\/9\/1394\/5608864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":12,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,1]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2018.288670","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9,1]]},"published":{"date-parts":[[2018,9,1]]}}}